BGM Stock Analysis: Buy, Sell, or Hold?
BGM - BGM Group Ltd. Class A Ordinary Shares
$8.65
0.06 (0.70%)
▲
5d:
-19.53%
30d:
+3239.77%
90d:
+3049.46%
WAIT
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Mar 10, 2026
0d
Get Alerted When BGM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BGM is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BGM is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BGM is currently trading at $8.65, which is considered slightly high relative to its 30-day fair value range of $-0.39 to $8.80.
Technical Outlook: Technically, BGM is in a uptrend. Immediate support is located at $8.36, while resistance sits at $10.78.
Market Sentiment: BGM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BGM is in a uptrend. Immediate support is located at $8.36, while resistance sits at $10.78.
Market Sentiment: BGM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$-0.39 -
$8.80
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
35.3%
All Signals
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.39 -
$8.80
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$8.36
Resistance Level
$10.78
Current Trend
Uptrend
Technical data as of
Oct 16, 2026
Fundamental Context
Revenue Growth (YoY)
69.8%
Profit Margin
-44.2%
Share & Embed Analysis
Last updated: October 18, 2026 6:39 AM ET
Data refreshes hourly during market hours. Next update: 7:39 AM
Data refreshes hourly during market hours. Next update: 7:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BGM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 58 HOLD |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$57 | 64 BUY |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 53 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$42 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
13 analysts |
$22 | 55 HOLD |
